News
01-15-2008, 03:12 PM
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
More... (http://www.news-medical.net/?id=34344)
More... (http://www.news-medical.net/?id=34344)